Compare RXRX & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RXRX | HUN |
|---|---|---|
| Founded | 2013 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2021 | 2004 |
| Metric | RXRX | HUN |
|---|---|---|
| Price | $3.74 | $9.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 11 |
| Target Price | $7.50 | ★ $12.09 |
| AVG Volume (30 Days) | ★ 14.7M | 2.2M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | ★ 14.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $74,681,000.00 | ★ $5,683,000,000.00 |
| Revenue This Year | $12.11 | $3.08 |
| Revenue Next Year | $82.52 | $5.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 26.92 | N/A |
| 52 Week Low | $2.77 | $7.30 |
| 52 Week High | $7.18 | $16.09 |
| Indicator | RXRX | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 33.07 |
| Support Level | $2.87 | N/A |
| Resistance Level | $4.03 | $9.99 |
| Average True Range (ATR) | 0.19 | 0.32 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 95.90 | 4.78 |
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.